Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Vermeer

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Journal of the American Academy of Dermatology|October 1, 1996
Is mycosis fungoides exacerbated by fluoxetine?M H Vermeer, R Willemze
The British Journal of Dermatology|September 24, 2017
MicroRNA-155 potentiates tumour development in mycosis fungoidesC P Tensen, M H Vermeer
Journal of the American Academy of Dermatology|August 21, 2001
Mouse fingers, a new computer-related skin disorderM H Vermeer, D P Bruynzeel
Nederlands Tijdschrift Voor Geneeskunde|December 28, 1999
[Two patients with Muir-Torre syndrome]M H Vermeer, H Neering, F H Menko
Journal of the American Academy of Dermatology|September 25, 2001
Should primary cutaneous Ki-1(CD30)-positive anaplastic large cell lymphoma in childhood be treated with multiple-agent chemotherapy?M H Vermeer, M W Bekkenk, R Willemze
Scandinavian Journal of Rheumatology|April 17, 2008
Hyperpigmentation of the skin due to hydroxychloroquineM J Rood, M H Vermeer, T W J Huizinga
Nederlands Tijdschrift Voor Geneeskunde|December 28, 1999
[Multiple clear-cell syringomas: a cutaneous marker for diabetes mellitus]R M Krijnen, T M Starink, M H Vermeer, et al.
The British Journal of Dermatology|December 5, 2013
Quantitation of tumour development correlates with prognosis in tumour stage (stage IIB) mycosis fungoidesS E Boonk, H Putter, L Koolhof, et al.
The British Journal of Dermatology|November 6, 2020
The importance of assessing blood tumour burden in cutaneous T-cell lymphomaM H Vermeer, J P Nicolay, J J Scarisbrick, et al.
The Journal of Investigative Dermatology|November 5, 1997
Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotypeJ A Kummer, M H Vermeer, D Dukers, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Journal of the American Academy of Dermatology|October 1, 1996
Is mycosis fungoides exacerbated by fluoxetine?M H Vermeer, R Willemze
The British Journal of Dermatology|September 24, 2017
MicroRNA-155 potentiates tumour development in mycosis fungoidesC P Tensen, M H Vermeer
Journal of the American Academy of Dermatology|August 21, 2001
Mouse fingers, a new computer-related skin disorderM H Vermeer, D P Bruynzeel
Nederlands Tijdschrift Voor Geneeskunde|December 28, 1999
[Two patients with Muir-Torre syndrome]M H Vermeer, H Neering, F H Menko
Journal of the American Academy of Dermatology|September 25, 2001
Should primary cutaneous Ki-1(CD30)-positive anaplastic large cell lymphoma in childhood be treated with multiple-agent chemotherapy?M H Vermeer, M W Bekkenk, R Willemze
Scandinavian Journal of Rheumatology|April 17, 2008
Hyperpigmentation of the skin due to hydroxychloroquineM J Rood, M H Vermeer, T W J Huizinga
Nederlands Tijdschrift Voor Geneeskunde|December 28, 1999
[Multiple clear-cell syringomas: a cutaneous marker for diabetes mellitus]R M Krijnen, T M Starink, M H Vermeer, et al.
The British Journal of Dermatology|December 5, 2013
Quantitation of tumour development correlates with prognosis in tumour stage (stage IIB) mycosis fungoidesS E Boonk, H Putter, L Koolhof, et al.
The British Journal of Dermatology|November 6, 2020
The importance of assessing blood tumour burden in cutaneous T-cell lymphomaM H Vermeer, J P Nicolay, J J Scarisbrick, et al.
The Journal of Investigative Dermatology|November 5, 1997
Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotypeJ A Kummer, M H Vermeer, D Dukers, et al.
Pageof 5